EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H28N2O.H2O.HCl |
| Net Charge | 0 |
| Average Mass | 342.911 |
| Monoisotopic Mass | 342.20741 |
| SMILES | CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl.O |
| InChI | InChI=1S/C18H28N2O.ClH.H2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H;1H2 |
| InChIKey | HUCIWBPMHXGLFM-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | amphiphile A surfactant molecule possessing both hydrophilic and lipophilic properties. |
| Biological Roles: | EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8). adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. EC 3.1.1.8 (cholinesterase) inhibitor An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8). |
| Applications: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has part bupivacaine hydrochloride (anhydrous) (CHEBI:31322) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has part dextrobupivacaine hydrochloride hydrate (CHEBI:77454) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has part levobupivacaine hydrochloride hydrate (CHEBI:77453) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role adrenergic antagonist (CHEBI:37887) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role amphiphile (CHEBI:59941) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role EC 3.1.1.8 (cholinesterase) inhibitor (CHEBI:37733) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role local anaesthetic (CHEBI:36333) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) is a racemate (CHEBI:60911) |
| IUPAC Names |
|---|
| rac-1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride—water (1/1) |
| rac-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride—water (1/1) |
| Synonyms | Source |
|---|---|
| 1-butyl-2',6'-pipecoloxylidide monohydrochloride monohydrate | ChEBI |
| (+/-)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride, monohydrate | ChemIDplus |
| 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate | ChEBI |
| bupivacaine hydrochloride | ChemIDplus |
| bupivacaine hydrochloride monohydrate | ChEBI |
| bupivacaine monohydrochloride monohydrate | ChEBI |
| Brand Name | Source |
|---|---|
| Marcaine | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Reaxys:13856665 | Reaxys |
| CAS:73360-54-0 | ChemIDplus |